MINI FUTURE LONG - ZEALAND PHARMA Share Price

DE000MB1S9D1

Delayed Börse Stuttgart 03:29:43 19/06/2024 pm IST
6.22 ^EUR	+2.98%

Current month	+1.17%
1 month	+10.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZEALAND PHARMA A/S

Latest news about ZEALAND PHARMA A/S

Health Care Flat as Traders Wait More Obesity-Drug Updates - Health Care Roundup	18/06	DJ
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants	13/06	GL
Transcript : Zealand Pharma A/S Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 04:00 PM	13/06
Zealand Pharma, Boehringer Ingelheim Weight Loss Compound Hits Midstage Endpoints for Liver Fibrosis	07/06	MT

More news

Quotes 5-day view

Date	Price	Change
19/24/19	6.22	+2.98%
18/24/18	6.04	-0.33%
17/24/17	6.06	-4.11%
14/24/14	6.32	+3.27%
13/24/13	6.12	+6.99%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 03:29 pm IST

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	ZEALAND PHARMA A/S
Issuer	Morgan Stanley
WKN	MB1S9D
ISIN	DE000MB1S9D1
Date issued	27/12/2022
Strike	189.5 kr
Maturity	Unlimited
Parity	10 : 1
Emission price	0.44 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	7.69 €
Lowest since issue	0.33 €

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Sector

More about the company

Ratings for Zealand Pharma A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Zealand Pharma A/S

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

640 DKK

Average target price

790.9 DKK

Spread / Average Target

+23.57%

Consensus